Thermo Fisher Scientific expands Bioprocess Design Centers to strengthen Asia’s biopharma manufacturing capacity
Posted: 5 December 2025 Thermo Fisher Scientific announces a significant expansion of its Bioprocess Design Centers across Asia, deepening its investment in the region’s rapidly advancing biopharmaceutical sector. The company is opening a new centre in Hyderabad, India,…
New MTPConnect report highlights strong commercial and clinical outcomes from its CTCM Medtech program
Posted: 5 December 2025 A new report has been released detailing the strong outcomes achieved through MTPConnect’s Clinical Translation Commercialisation Medtech (CTCM) Programme, highlighting the advances made by emerging Australian medtech companies supported through the initiative. Speaking at…
CSL Seqirus opens world-class $1bn vaccine and antivenom manufacturing facility in Melbourne
Posted: 5 December 2025 Australia’s onshore vaccine manufacturing capabilities took a leap forward today as The Hon Mark Butler MP, Minister for Health, Disability and Ageing, opened CSL Seqirus’ state-of-the-art cell-based influenza vaccine and antivenom manufacturing facility in…
Florey Institute study reveals neural activity directly drives faster glioma growth
Posted: 1 December 2025 A new study led by The Florey has revealed that heightened neural excitability in the brain directly drives increased growth of glioma, an aggressive and currently incurable form of brain cancer. “Glioma is a…
Akesa unveils new Aksys digital platform to streamline access to private-script medicines in hospitals
Posted: 1 December 2025 Akesa has launched the Aksys platform as a digital solution designed to simplify how Australian hospitals access non-Pharmaceutical Benefits Scheme (PBS) reimbursed prescription medicines. The platform is positioned as a major advancement in improving…
4DMedical celebrated as a high-growth Australian innovator, ranking seventh in Deloitte’s Tech Fast 50
Posted: 1 December 2025 4DMedical has been ranked seventh in the Deloitte 2025 Tech Fast 50 after recording a 715% increase in revenue across the past three years. The ranking is a recognition of the organisation’s rapid expansion…
Cartherics announces appointment of Dr Ian Nisbet as Chief Executive Officer
Posted: 28 November 2025 Cartherics Pty Ltd has announced that Dr Ian Nisbet has been appointed Chief Executive Officer as part of a planned leadership transition designed to support the company’s next phase of growth. The announcement followed…
Amplia Therapeutics receives positive FDA feedback regarding planned Phase 2b/3 pancreatic cancer trial
Posted: 28 November 2025 Amplia Therapeutics Limited announced that positive feedback had been received from the United States Food and Drug Administration (FDA) following a recent Type D meeting, providing support for the company’s planned late-stage clinical trial…
WEHI’s new $8 Million PURPLE translational platform to accelerate new approaches to pancreatic cancer treatment
Posted: 28 November 2025 WEHI’s new groundbreaking digital platform uniting patients, clinicians and researchers was unveiled as a major step toward transforming pancreatic cancer care, supported through an $8 million philanthropic commitment from The Hemstritch Centre of Excellence…
AusBiotech’s Early-Stage Innovation Forum awarded to autoimmune biologic pioneer Professor Claudia Nold
Posted: 26 November 2025 A pioneering biologic aimed at interferon-driven autoimmune diseases was recognised with the top honour at this year’s Early-Stage Innovation Forum (ESIF), held during the AusBiotech International Conference 2025 in Melbourne. The accolade was awarded…
Peter Mac led study reveals new insights into how the brain’s barrier influences tumour behaviour
Posted: 26 November 2025 A new investigation from Peter MacCallum Cancer Centre is reported to have uncovered how cells forming the brain’s protective barrier act as “gatekeepers”, influencing how some brain tumours responded when nutrients were limited. Lead…
Telix Pharmaceuticals opens new manufacturing facility in Yokohama, Japan
Posted: 25 November 2025 Telix announced it has officially opened Telix Manufacturing Solutions (TMS) in Yokohama, Japan, marking the Company’s first cyclotron manufacturing facility in the Asia Pacific region. The site was established to expand access to radiopharmaceuticals…
